News Digest 24.07.2023 - 25.07.2023

Regulators

Putin approves law banning medical interventions aimed at gender reassignment

Russian President Vladimir Putin signed a law banning medical interventions aimed at gender reassignment, unless they are due to medical indications. A ban on the use of sex reassignment drugs has been officially established. According to the novel, by decision of the medical commission, operations will be carried out aimed at treating congenital anomalies, genetic and endocrine diseases associated with the formation of genital organs in children. The procedure for issuing decisions and the list of medical organizations will be approved by the Government of the Russian Federation.

Source: https://vademec.ru/news/2023/07/25/putin-utverdil-zakon-o-zaprete-meditsinskikh-vmeshatelstv-napravlennykh-na-smenu-pola/

The State Duma proposed to hide data on foreign supplies of pharmaceutical substances

State Duma deputy Airat Farrakhov proposed to protect foreign suppliers of pharmaceutical substances, excipients and equipment necessary for pharmaceutical production from sanctions and depersonalize some of the information about the supply contained in customs declarations. The parliamentarian sent a corresponding appeal to the Federal Customs Service.

Source: https://vademec.ru/news/2023/07/24/v-gosdume-predlozhili-skryt-dannye-o-zarubezhnykh-postavkakh-farmsubstantsii/


Market news

The digital syringe machine received the registration certificate of Roszdravnadzor

The scientific team of the MISIS University has developed a digital syringe machine, thanks to which even a person without special training can give an injection. The device called "Komarik" successfully passed pilot testing on the basis of the Kommunarka Multidisciplinary Clinical Center of the Moscow Health Department and entered the market with grant support from the Skolkovo Foundation. This device has no analogues in the world, the press service of the university said.

Source: https://medvestnik.ru/content/news/Cifrvoi-shpric-avtomat-poluchil-registracionnoe-udostoverenie-Roszdravnadzora.html


Other

Experts have created an atlas of human kidney cells

Scientists from Harvard Medical School, the University of California, the University of Michigan, the Indiana University School of Medicine and the University of Washington, with the support of the US National Institutes of Health (NIH), have developed an atlas of human kidney cells. The results of the study are published on the NIH website with a link to the journal Nature.

The Kidney Tissue Atlas contains information on 51 major types of kidney cells, including rare and new populations. In addition, 28 states of cells are described there, which correspond to their damage or disease. The atlas also contains data on genes, interactive 3D models of cells and their

Source: https://medvestnik.ru/content/news/Eksperty-sozdali-atlas-kletok-pochek-cheloveka.html


New registered medical devices

We publish a list of new medical devices registered from 07/14/2023 to 07/21/2023

https://asiamc.ru/uploads/blogs/2023-07-28/medregs_20230725.pdf

News

News Digest 06.11.2026 — 13.11.2026
13.11.2026
CNIIOIZ Presents Methodological Guidelines for Implementing AI-Powered Medical Devices; Russian Ministry of Health Clarifies Procedures for Electronic Waybills for Medical Waste Transport; Medpribor Acquires Russian Partner of Siemens Healthineers
More
News Digest 23.10.2026 — 06.11.2026
06.11.2026
Roszdravnadzor Suspends Registration of Medical Devices on a Large Scale; FAS and Roszdravnadzor Clarify Specific Issues Regarding Public Procurement of Medical Device Maintenance Services; VNIIIMT has prepared methodological guidelines for clinical monitoring reports on medical devices
More
News Digest 16.10.2026 — 23.10.2026
23.10.2026
The government has amended the procedure for verifying the Russian origin of products manufactured by institutions and enterprises within the penal system (UIS); Lawmakers propose raising the age limit for children to be hospitalized alongside a parent; Chinese companies have emerged as leaders in three out of five key segments of government procurement for laboratories
More